Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility

Biochemical Journal

Volumn 362, Issue 2, 2002, Pages 443-451

  Burton, David ^a   Abdulrazzak, Hassan ^a   Knott, Adam ^a   Elliott, Kathryn ^a   Redwood, Charles ^a   Watkins, Hugh ^a   Marston, Steven ^a   Ashley, Chris ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Calcium; Motility; Regulation

Indexed keywords

ADENOSINETRIPHOSPHATE; BIOASSAY; ESCHERICHIA COLI; FIBERS; MUSCLE; PROTEINS;

MUTATIONS;

CARDIOLOGY;

ACTIN; ARGININE; CALCIUM ION; GLYCINE; MYOSIN ADENOSINE TRIPHOSPHATASE; SERINE; TROPOMYOSIN; TROPONIN C; TROPONIN I; VANADIC ACID;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GUINEA PIG; HEART MUSCLE CONTRACTILITY; HYPERTROPHIC CARDIOMYOPATHY; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; WESTERN BLOTTING;

ACTINS; AMINO ACID SUBSTITUTION; ANIMALS; CALCIUM; CARDIOMYOPATHY, HYPERTROPHIC; GUINEA PIGS; HEART; HUMANS; MUSCLE FIBERS; MUTATION, MISSENSE; MYOCARDIAL CONTRACTION; MYOSIN SUBFRAGMENTS; PHENOTYPE; TROPOMYOSIN; TROPONIN I;

ANIMALIA; CAVIA PORCELLUS; ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS; SUS SCROFA;

EID: 0036499710     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3620443     Document Type: Article

References (39)

1. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4122 subjects in the CARDIA study
2. The in vitro motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy
3. Effect of hypertrophic cardiomyopathy mutations in human cardiac α-tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay
4. 2+ regulatory properties of reconstituted thin filaments depend on the ratio of mutant to wild type peptide
5. Functional consequences of troponin T mutations found in hypertrophic cardiomyopathy
6. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy
7. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
8. Sudden cardiac death in familial hypertrophic cardiomyopathy is associated with a novel mutation in the troponin I gene
9. Deletion in the troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy
10. Effect of Arg145Gly mutation in human cardiac troponin on the ATPase activity of cardiac myofibrils
11. Recombinant troponin I substitution and calcium responsiveness in skinned cardiac muscle
12. Molecular cloning of human cardiac troponin I by potymerase chain reaction
13. Use of T7 RNA-polymerase to direct expression of cloned genes
14. Functional analysis of human cardiac troponin by the in vitro motility assay: Comparison of adult, foetal and failing hearts
15. Effect of pH, phosphate and ADP on relaxation of myocardium after photolysis of diazo 2
16. Calculator programmes used for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells
17. Troponin replacement in permeabilised cardiac muscle. Reversible extraction of troponin I by incubation with vanadate
18. 2+: The thin filament is switched as a single cooperative unit
19. Assays for actin sliding movement over myosin coated surfaces
20. A simple method for automatic tracking of actin filaments in the motility assay
21. 2+-dependent effects on actin-tropomyosin filament motility
22. Transgenic modelling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy
23. A truncated troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy
24. A synthetic peptide mimics troponin I function in the calcium dependent regulation of muscle contraction
25. The biological importance of each amino acid residue of the troponin I inhibitory sequence 104-115 in the interaction with troponin C and tropomyosin-actin
26. Troponin I isoform expression in human heart
27. Comparison of amino acid sequence of troponin I from different striated muscles
28. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury
29. Transgenic mouse model of stunned myocardium
30. 2-terminal interface of cardiac troponin I modulated myofilament activation
31. Systematic mapping of regions of human cardiac troponin I involved in binding to cardiac troponin C: N- and C-terminal low affinity contributing regions
32. Calcium and magnesium dependent interactions between the C-terminus of troponin I and the N-terminal, regulatory domain of troponin C
33. Effects of phosphorylation and mutation R145G on human cardiac troponin I function
34. Cardiac and skeletal myopathies: Can genotype explain phenotype?
35. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy
36. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy
37. Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: Insights into disease pathogenesis and troponin function
38. Cardiac troponin T mutations: Correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice
39. Mutations in the γ2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: Evidence for the central role of energy compromise in disease pathogenesis